Potent P2Y12 Inhibitors in Low-Risk Patients: Is There a Medical Need?

MLA

Silvain, Johanne, et al. “Potent P2Y12 Inhibitors in Low-Risk Patients: Is There a Medical Need?” Journal of the American College of Cardiology, vol. 67, no. 6, Feb. 2016, pp. 614–17. EBSCOhost, https://doi.org/10.1016/j.jacc.2015.11.043.

APA

Silvain, J., Kerneis, M., & Montalescot, G. (2016). Potent P2Y12 Inhibitors in Low-Risk Patients: Is There a Medical Need? Journal of the American College of Cardiology, 67(6), 614–617. https://doi.org/10.1016/j.jacc.2015.11.043

Chicago

Silvain, Johanne, Mathieu Kerneis, and Gilles Montalescot. 2016. “Potent P2Y12 Inhibitors in Low-Risk Patients: Is There a Medical Need?” Journal of the American College of Cardiology 67 (6): 614–17. doi:10.1016/j.jacc.2015.11.043.